Andrew Gengos, CFO of Terns Pharmaceuticals ($TERN), bought shares on the open market five times over the past year, totaling about $96,400. His most recent purchase was on June 27, 2025. With no sales recorded, his buying activity ranks 2,427th among 4,983 insiders, below the average purchase of $1.5 million across 3.3 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 14, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | A | Common Stock | 68750 | $0.00 | 101,788.0000 | 91,701,529 | 208.09% | 0.07% |
| Jan. 14, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | A | Stock Option (Right to Buy) | 137500 | $0.00 | 137,500.0000 | 91,701,529 | 9999.99% | 0.15% |
| Oct. 8, 2025 | Turn Therapeutics Inc. | $TTRX | Gengos Andrew | Director | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.93 | 25,000.0000 | 79,507,474 | 25.00% | 0.01% |
| June 27, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.93 | 20,000.0000 | 79,507,474 | 33.33% | 0.01% |
| June 13, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.75 | 5,000.0000 | 79,507,474 | 9999.99% | 0.01% |
| June 13, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.72 | 10,000.0000 | 79,507,474 | 100.00% | 0.01% |
| June 16, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | P | Common Stock | 5000 | $3.95 | 15,000.0000 | 79,507,474 | 50.00% | 0.01% |
| Feb. 24, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Gengos Andrew | Chief Financial Officer | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 79,507,474 | 9999.99% | 0.94% |
| Sept. 3, 2024 | LeonaBio, Inc. | $LONA | Gengos Andrew | CFO and Chief Business Officer | A | Common Stock | 5000 | $0.00 | 98,804.0000 | 0 | 5.33% | 0.00% |
| Sept. 5, 2024 | LeonaBio, Inc. | $LONA | Gengos Andrew | CFO and Chief Business Officer | S | Common Stock | 1272 | $0.57 | 97,532.0000 | 0 | 1.29% | 0.00% |
| May 20, 2024 | LeonaBio, Inc. | $LONA | Gengos Andrew | CFO and Chief Business Officer | A | Common Stock | 10000 | $1.34 | 93,804.0000 | 0 | 11.93% | 0.00% |
| Jan. 5, 2024 | LeonaBio, Inc. | $LONA | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | S | Common Stock | 1208 | $2.91 | 83,804.0000 | 0 | 1.42% | 0.00% |
| Jan. 4, 2024 | LeonaBio, Inc. | $LONA | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | A | Common Stock | 5000 | $0.00 | 85,012.0000 | 0 | 6.25% | 0.00% |
| Feb. 14, 2024 | LeonaBio, Inc. | $LONA | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | S | Common Stock | 1208 | $2.91 | 83,804.0000 | 0 | 1.42% | 0.00% |
| Jan. 4, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | A | Common Stock | 5000 | $0.00 | 85,012.0000 | 0 | 6.25% | 0.00% |
| June 7, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 422 | $3.36 | 65,434.0000 | 0 | 0.65% | 0.00% |
| June 7, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 11719 | $3.44 | 80,012.0000 | 0 | 17.16% | 0.00% |
| June 7, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 2859 | $3.40 | 68,293.0000 | 0 | 4.37% | 0.00% |
| June 5, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 10000 | $3.02 | 65,012.0000 | 0 | 18.18% | 0.00% |
| June 2, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 6582 | $2.86 | 16,594.0000 | 0 | 65.74% | 0.00% |
| June 2, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 10012 | $2.75 | 10,012.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 3418 | $2.95 | 20,012.0000 | 0 | 20.60% | 0.00% |
| June 5, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 10000 | $3.00 | 45,012.0000 | 0 | 28.56% | 0.00% |
| June 5, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 10000 | $3.00 | 55,012.0000 | 0 | 22.22% | 0.00% |
| June 5, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | P | Common Stock | 15000 | $3.00 | 35,012.0000 | 0 | 74.96% | 0.00% |
| May 18, 2023 | LeonaBio, Inc. | $LONA | Gengos Andrew | See Below | A | Stock Options (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |